Tema Healthcare AI ETF (NASDAQ: HLTH) is a newly launched, actively managed, pure-play ETF focused on artificial intelligence applications in healthcare. According to Tema, the fund targets companies using AI in drug discovery, diagnostics, clinical robotics, and technologies that improve patient care.
HLTH is advised by Tema ETFs and sub-advised by Tidal Investments, with portfolio management led by physician-investor Dr. David Song, MD, PhD, CFA. The ETF lists on NASDAQ on July 21, 2026, has a gross expense ratio of 0.75%, and trades under ticker HLTH. As of July 21, 2026, top holdings include 10x Genomics, Cytokinetics, Illumina, Intuitive Surgical, and Vertex Pharmaceuticals, each weighted around 4–5%. The fund is sector-focused in healthcare and information technology and carries associated concentration, regulatory, and innovation risks highlighted in its prospectus.